---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced the publication of a study validating performance of a novel algorithm designed to integrate the DecisionDx ® -Melanoma gene expression profile (GEP) test with clinicopathologic features (i31-GEP SLNB) to determine sentinel lymph node biopsy (SLNB) positivity risk in patients with cutaneous melanoma."
publishedDateTime: 2021-11-05T21:01:00Z
originalUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
webUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "CLcGNxF0PZndmqDoJcR4wNr+LK3DjzEs6iHf5DD4zTpXWag/u40tMeAOwPlehIxwyxqFl36DLyVx1UUWjuJOjhm9tKV/+t0rWir3URK6rv427eALQ8751rbQnSVk+Xk0+Ia1pvXTg9iz+RvjnZ/xT4c4X/ekFZV0NOwVKyabQQsBinOxygldmBDbbQWxufaeBODdIgJy+G3LM+7j0BuifFFoe8xgIQGPxldsRibY00DJEVMERdG5IOpHtW65Vo22669mbVkaDfM5M+FXQwLqddwJlnWlFCXdrQRugG7bm1vDjS7g7etxTi79DDjHyqHJSi/iSYJ4bRbgCgEAPzfYLfRBQXmXakdLSI6KSu/N0BE=;vTDZ4L4JSZhS6Kos7t0XFw=="
---

